Cirrhosis with non alcoholic steatohepatatis: Role of tamoxifen;Cirrhose avec steatohepatite non alcoolique: Role du tamoxifene

Gastroenterologie Clinique et Biologique

Volumn 24, Issue 11, 2000, Pages 1122-1123

  Dray, X ^a   Tainturier, M H ^a   De La Lande, P ^a   Marty, O ^a   Mallet, L ^a  

^a SAINT JOSEPH HOSPITAL   (France)

Author keywords

Cirrhosis; Non alcoholic steato hepatitis; Tamoxifene

Indexed keywords

TAMOXIFEN; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;

AGED; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CASE REPORT; DISEASE COURSE; DISEASE PREDISPOSITION; FEMALE; HEPATITIS; HUMAN; LIVER CIRRHOSIS; RISK FACTOR; CHEMICALLY INDUCED DISORDER; FATTY LIVER; IATROGENIC DISEASE; LIVER; PATHOLOGY; TOXIC HEPATITIS;

AGED; ANTINEOPLASTIC AGENTS, HORMONAL; FATTY LIVER; FEMALE; HEPATITIS, TOXIC; HUMANS; IATROGENIC DISEASE; LIVER; LIVER CIRRHOSIS; TAMOXIFEN;

EID: 0034533252     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Nonalcoholic steatohepatitis
2. Steatohepatitis: A tale of two 'hits'?
3. Steatohepatitis-inducing drugs cause mitochondrial dysfunction and lipid peroxidation in rat hepatocytes
4. Tamoxifen-associated steatohepatitis. Report of three cases
5. Tamoxifen-induced steatohepatitis
6. Tamoxifen-induced steatohepatitis
7. Cirrhosis with steatohepatitis after adjuvant tamoxifen
8. Bezafibrate for tamoxifen-induced non-alcoholic steatohepatitis
9. Ursodesoxycholic acid or clofibrate in the treatment of non-alcohol-induced steatohepatitis: A pilot study
10. Tamoxifen-induced fatty liver in patients with breast cancer